Sympathoexcitation in response to cardiac and pulmonary afferent stimulation of TRPA1 channels is attenuated in rats with chronic heart failure.
Afferent Pathways
/ physiopathology
Animals
Arterial Pressure
Chronic Disease
Ganglia, Spinal
/ metabolism
Heart
/ innervation
Heart Failure
/ physiopathology
Heart Rate
Hemodynamics
Lung
/ innervation
Myocardial Infarction
/ physiopathology
Rats
Rats, Sprague-Dawley
Reflex
/ drug effects
Sympathetic Nervous System
/ physiopathology
TRPA1 Cation Channel
/ agonists
autonomic dysfunction
cardiovascular reflexes
heart failure
sensory afferents
sympathoexcitation
Journal
American journal of physiology. Heart and circulatory physiology
ISSN: 1522-1539
Titre abrégé: Am J Physiol Heart Circ Physiol
Pays: United States
ID NLM: 100901228
Informations de publication
Date de publication:
01 04 2019
01 04 2019
Historique:
pubmed:
2
2
2019
medline:
8
2
2020
entrez:
2
2
2019
Statut:
ppublish
Résumé
Excessive sympathoexcitation characterizes the chronic heart failure (CHF) state. An exaggerated cardiac sympathetic afferent reflex (CSAR) contributes to this sympathoexcitation. Prior studies have demonstrated that the CSAR to capsaicin [transient receptor potential (TRP) vanilloid 1 agonist] is exaggerated in CHF animal models. We recently discovered that capsaicin application to the lung visceral pleura in anesthetized, vagotomized, open-chested rats increases mean arterial pressure (MAP), heart rate (HR), and renal sympathetic nerve activity (RSNA). We named this response the pulmonary spinal afferent reflex (PSAR). Due to the similarities between TRP vanilloid 1 and TRP ankyrin 1 (TRPA1) channels as well as the excessive sympathoexcitation of CHF, we hypothesized that stimulation of the CSAR and PSAR with a specific TRPA1 agonist would result in an augmented response in CHF rats (coronary ligation model) compared with sham control rats. In response to a TRPA1 agonist, both CSAR and PSAR in sham rats resulted in biphasic changes in MAP and increases in HR and RSNA 10-12 wk postmyocardial infarction (post-MI). These effects were blunted in CHF rats. Assessment of TRPA1 expression levels in cardiopulmonary spinal afferents by immunofluorescence, quantitative RT-PCR, and Western blot analysis 10-12 wk post-MI all indicates reduced expression in CHF rats but no reduction at earlier time points. TRPA1 protein was reduced in a dorsal root ganglia cell culture model of inflammation and simulated tissue ischemia, raising the possibility that the in vivo reduction of TRPA1 expression was, in part, caused by CHF-related tissue ischemia and inflammation. These data provide evidence that reflex responses to cardiopulmonary spinal afferent TRPA1 stimulation may be attenuated in CHF rather than enhanced. NEW & NOTEWORTHY Excessive sympathoexcitation characterizes chronic heart failure (CHF). The contribution of transient receptor potential ankyrin 1 (TRPA1) channel-mediated reflexes to this sympathoexcitation is unknown. We found that application of TRPA1 agonist to the heart and lung surface resulted in increased heart rate and sympathetic output and a biphasic change in mean arterial pressure in control rats. These effects were attenuated in CHF rats, decreasing the likelihood that TRPA1 channels contribute to cardiopulmonary afferent sensitization in CHF.
Identifiants
pubmed: 30707612
doi: 10.1152/ajpheart.00696.2018
pmc: PMC6483016
doi:
Substances chimiques
TRPA1 Cation Channel
0
Trpa1 protein, rat
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
H862-H872Subventions
Organisme : NIGMS NIH HHS
ID : P30 GM127200
Pays : United States
Organisme : NHLBI NIH HHS
ID : R00 HL123471
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL121012
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL126796
Pays : United States
Références
Curr Probl Cardiol. 2015 May;40(5):207-38
pubmed: 25882781
Cell. 2003 Mar 21;112(6):819-29
pubmed: 12654248
Physiol Rep. 2018 Jun;6(12):e13742
pubmed: 29906340
J Appl Physiol (1985). 2016 Mar 15;120(6):580-91
pubmed: 26718787
Environ Health Perspect. 2011 Jul;119(7):951-7
pubmed: 21377951
J Peripher Nerv Syst. 2007 Jun;12(2):121-30
pubmed: 17565537
J Physiol. 2017 Apr 15;595(8):2519-2534
pubmed: 28116751
Am J Respir Cell Mol Biol. 2009 Jun;40(6):756-62
pubmed: 19059884
Eur Heart J. 1990 Apr;11 Suppl A:3-11
pubmed: 2188836
J Appl Physiol (1985). 2010 May;108(5):1365-75
pubmed: 20185628
Am J Physiol. 1999 Aug;277(2):H812-7
pubmed: 10444509
Hypertension. 2005 Jun;45(6):1173-81
pubmed: 15897358
Hypertension. 2014 Oct;64(4):745-55
pubmed: 24980663
N Engl J Med. 1990 Jul 26;323(4):236-41
pubmed: 2195340
Circ Res. 1986 Apr;58(4):512-22
pubmed: 3698217
Exp Physiol. 2006 Jan;91(1):89-102
pubmed: 16282366
J Am Coll Cardiol. 1996 Oct;28(4):964-71
pubmed: 8837575
J Appl Physiol (1985). 1999 Apr;86(4):1273-82
pubmed: 10194213
Am Heart J. 1999 Nov;138(5 Pt 1):890-9
pubmed: 10539820
Channels (Austin). 2008 Jul-Aug;2(4):287-98
pubmed: 18769139
Cell. 2006 Mar 24;124(6):1269-82
pubmed: 16564016
Int J Cardiol. 2009 Jul 10;135(3):302-7
pubmed: 18582965
Am J Cardiol. 1998 Sep 1;82(5):688-90, A8
pubmed: 9732906
N Engl J Med. 1984 Sep 27;311(13):819-23
pubmed: 6382011
Am J Physiol Regul Integr Comp Physiol. 2012 Jun;302(11):R1260-70
pubmed: 22496362
Neurosci Lett. 2006 Mar 13;395(3):215-9
pubmed: 16309834
Physiol Res. 2017 Jul 18;66(3):425-439
pubmed: 28730837
Neuron. 2004 Mar 25;41(6):849-57
pubmed: 15046718
J Physiol. 2010 Dec 15;588(Pt 24):5033-47
pubmed: 21041525
J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):72A-84A
pubmed: 8376699
J Am Coll Cardiol. 1998 Feb;31(2):391-8
pubmed: 9462584
J Appl Physiol (1985). 2015 Feb 1;118(3):273-81
pubmed: 25414245
J Appl Physiol (1985). 1999 Apr;86(4):1264-72
pubmed: 10194212
J Appl Physiol (1985). 1993 May;74(5):2345-52
pubmed: 8335566
Am J Physiol Heart Circ Physiol. 2019 Jan 1;316(1):H70-H79
pubmed: 30289294
Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H311-21
pubmed: 17965282
Toxicol Appl Pharmacol. 2017 Jun 1;324:51-60
pubmed: 27746315
J Auton Nerv Syst. 1987 Aug;20(2):155-66
pubmed: 3312381
Physiol Rev. 2007 Jan;87(1):165-217
pubmed: 17237345
Herz. 1991 Apr;16(2):82-91
pubmed: 2066056
J Appl Physiol (1985). 1992 Mar;72(3):1050-6
pubmed: 1568959
J Appl Physiol (1985). 1992 Dec;73(6):2305-13
pubmed: 1490937
Nature. 2007 Feb 1;445(7127):541-5
pubmed: 17237762
Am J Physiol. 1996 Sep;271(3 Pt 2):R751-6
pubmed: 8853400
Am J Cardiol. 1997 Apr 15;79(8):1128-31
pubmed: 9114781
Circulation. 2000 Mar 21;101(11):1267-73
pubmed: 10725286
Am J Physiol. 1997 Dec;273(6):H2664-71
pubmed: 9435602
Jpn Heart J. 2004 Mar;45(2):183-93
pubmed: 15090695
Am J Physiol Heart Circ Physiol. 2015 Mar 1;308(5):H447-55
pubmed: 25502111
Prog Biophys Mol Biol. 2004 Feb-Apr;84(2-3):217-32
pubmed: 14769437
Cell. 2015 Apr 23;161(3):622-633
pubmed: 25892222
Heart Fail Rev. 2000 Mar;5(1):57-71
pubmed: 16228916
Annu Rev Biochem. 2007;76:387-417
pubmed: 17579562
Can J Cardiol. 1986 Jul;Suppl A:40A-45A
pubmed: 3756596
Neuroscience. 1992 Aug;49(3):715-37
pubmed: 1380140